Antigen Presentation to Celiac Lesion-Derived T Cells of a 33-Mer Gliadin Peptide Naturally Formed by Gastrointestinal Digestion
about
sameAs
Celiac disease: prevalence, diagnosis, pathogenesis and treatmentIdentification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprueNovel therapeutic/integrative approaches for celiac disease and dermatitis herpetiformisVisualization of transepithelial passage of the immunogenic 33-residue peptide from alpha-2 gliadin in gluten-sensitive macaquesCeliac disease, wheat allergy, and gluten sensitivity: when gluten free is not a fadTransepithelial transport and enzymatic detoxification of gluten in gluten-sensitive rhesus macaquesSecretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease.Pathophysiology of celiac diseaseCeliac disease T-cell epitopes from gamma-gliadins: immunoreactivity depends on the genome of origin, transcript frequency, and flanking protein variationMaize prolamins could induce a gluten-like cellular immune response in some celiac disease patients.Generation of food-grade recombinant Lactobacillus casei delivering Myxococcus xanthus prolyl endopeptidase.Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis.Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.Coeliac Disease - New Pathophysiological Findings and Their Implications for TherapyResolving multiple protein-peptide binding events: implication for HLA-DQ2 mediated antigen presentation in celiac disease.Increased bacterial translocation in gluten-sensitive mice is independent of small intestinal paracellular permeability defectCeliac disease: pathogenesis of a model immunogenetic disease.Rapid isolation of gluten-digesting bacteria from human stool and saliva by using gliadin-containing plates.Antigen presentation in celiac disease.Enzymatic strategies to detoxify gluten: implications for celiac disease.In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.The adaptive immune response in celiac disease.Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.Identification and molecular characterization of oat peptides implicated on coeliac immune response.Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.Electrochemical genosensors in food safety assessment.Screening sourdough samples for gliadin-degrading activity revealed Lactobacillus casei strains able to individually metabolize the coeliac-disease-related 33-mer peptide.Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.Extraintestinal manifestations of celiac disease: 33-mer gliadin binding to glutamate receptor GRINA as a new explanation.Inhibition of HLA-DQ2-mediated antigen presentation by analogues of a high affinity 33-residue peptide from alpha2-gliadin.New and developing therapies for celiac disease.Abrogation of Immunogenic Properties of Gliadin Peptides through Transamidation by Microbial Transglutaminase Is Acyl-Acceptor Dependent.Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations.An electrochemical deamidated gliadin antibody immunosensor for celiac disease clinical diagnosis.Deamidation of gliadin peptides in lamina propria: implications for celiac disease.The effects of atorvastatin on gluten-induced intestinal T cell responses in coeliac disease.Scientific Opinion on the assessment of allergenicity of GM plants and microorganisms and derived food and feedInvolvement of CD40-CD40 ligand in uncomplicated and refractory celiac disease.
P2860
Q22305490-A92A2D81-99A3-464A-A5F8-79ADBA9B0625Q24538575-A4C9C890-B7BC-4118-B31C-3D0CA0F302A8Q27010008-420977A7-3C5C-42E4-B9A9-88CCCFFDD9A2Q27331370-EA1CAE07-51CA-420F-85DF-AB31A00BBF13Q28257289-666B30E5-3341-425B-B089-A9D88E125EF4Q28472401-671FF4F9-A186-4C19-9E6A-CEF4A9ACE371Q34009143-547B8A01-D95F-4683-B9AA-24B1C7D190B5Q34307239-985CB97A-85C4-4049-8AC7-C277AE878066Q34314995-B31F7087-B8A6-4B10-8DB4-555C7DD1B7C4Q34656866-1ACB72FB-11BB-476B-BBB6-3C3CC08B0A9AQ34661417-E8713D65-0EB3-4141-8263-3CA0781B582DQ34903220-0A25AEE7-8C93-45E5-BB22-0BD477C00377Q35835769-22DB427F-6AEE-422B-B788-F0D4C5FA20C5Q35885793-3619C6B2-7D4A-4E87-BAF1-751DFB049E63Q36055610-E60737E0-7543-4A12-B22E-AEC7EB23D113Q36426072-809FE570-6EAF-4539-AE77-D2EC2D9F3526Q36698131-DBBCB324-0A5D-49AF-9D75-009249B6A865Q37071537-C9D31A9F-ACAD-46AA-A67C-11B57DF3CE22Q37430981-86DAF2F3-7ECE-4560-8F1A-281625CA1359Q37806959-F08877BD-F754-4C44-BB51-BFFC4B4D5CE8Q37979161-B0A3E787-ADF1-4944-B2F9-7F3511CFAD0EQ38005620-F644A517-820E-46B2-BBD2-86A829824903Q38021639-7616A67D-E0F4-4CD7-81AE-E38AC9258890Q38279890-32642D8B-1C64-43F3-8FBA-A52510955598Q38747102-49E1147F-51CB-4764-BE5A-EF02957F42CFQ38824682-B6B75E24-BB28-436D-A2AB-E2F3EACD8FEBQ38942978-F3C51B73-3953-4104-A32E-5DB03AE48B2FQ39883542-C3AC0076-57CC-41A6-B7CC-2BA55D47B91DQ39883644-33B7105B-9AF6-466B-BCA7-5A28487EB11CQ39909904-7F24810A-912C-455E-80DF-A5CFE224FE9AQ41131780-E12A39B4-F269-4920-984D-3963FF4B6D48Q41173044-B83F0E42-DE04-4FA7-8F21-CC2DEC62FCA3Q41583702-6967594C-EBF9-40AA-AEFB-6DFA5D6A2786Q42482567-F3578EDE-CEE1-4A93-89E7-0618F7D2F77CQ42873027-8E8E9AAE-146F-408C-ABFF-5081E2EE7F00Q45598487-A5DD337B-663A-496B-9F73-1F9F0FBABC3DQ46446222-072A1840-DB84-4EC6-ABD8-9A91D6C4819FQ46758935-BD663FD5-3D1F-4D20-A7D3-91A0D29B2F43Q47148622-1ACA575C-8A4A-4F16-8088-2FBA6F7B2788Q52605789-CBD9E757-111B-40DA-A4DF-F93255C9AEE4
P2860
Antigen Presentation to Celiac Lesion-Derived T Cells of a 33-Mer Gliadin Peptide Naturally Formed by Gastrointestinal Digestion
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Antigen Presentation to Celiac ...... by Gastrointestinal Digestion
@ast
Antigen Presentation to Celiac ...... by Gastrointestinal Digestion
@en
Antigen Presentation to Celiac ...... by Gastrointestinal Digestion
@en-gb
Antigen presentation to celiac ...... by gastrointestinal digestion.
@nl
type
label
Antigen Presentation to Celiac ...... by Gastrointestinal Digestion
@ast
Antigen Presentation to Celiac ...... by Gastrointestinal Digestion
@en
Antigen Presentation to Celiac ...... by Gastrointestinal Digestion
@en-gb
Antigen presentation to celiac ...... by gastrointestinal digestion.
@nl
altLabel
Antigen presentation to celiac ...... by gastrointestinal digestion.
@ast
Antigen presentation to celiac ...... by gastrointestinal digestion.
@en
prefLabel
Antigen Presentation to Celiac ...... by Gastrointestinal Digestion
@ast
Antigen Presentation to Celiac ...... by Gastrointestinal Digestion
@en
Antigen Presentation to Celiac ...... by Gastrointestinal Digestion
@en-gb
Antigen presentation to celiac ...... by gastrointestinal digestion.
@nl
P2093
P1476
Antigen presentation to celiac ...... by gastrointestinal digestion
@en
P2093
Burkhard Fleckenstein
Chaitan Khosla
Elin Bergseng
Ludvig M Sollid
Øyvind Molberg
P304
P356
10.4049/JIMMUNOL.173.3.1757
P407
P577
2004-08-01T00:00:00Z